- Open Access
Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity
Journal of Nanobiotechnology volume 9, Article number: 29 (2011)
Nanomaterials such as SiO2 nanoparticles (SiO2NP) are finding increasing applications in the biomedical and biotechnological fields such as disease diagnostics, imaging, drug delivery, food, cosmetics and biosensors development. Thus, a mechanistic and systematic evaluation of the potential biological and toxic effects of SiO2NP becomes crucial in order to assess their complete safe applicability limits.
In this study, human monocytic leukemia cell line THP-1 and human alveolar epithelial cell line A549 were exposed to a range of amorphous SiO2NP of various sizes and concentrations (0.01, 0.1 and 0.5 mg/ml). Key biological indicators of cellular functions including cell population density, cellular morphology, membrane permeability, lysosomal mass/pH and activation of transcription factor-2 (ATF-2) were evaluated utilizing quantitative high content screening (HCS) approach and biochemical techniques. Despite the use of extremely high nanoparticle concentrations, our findings showed a low degree of cytotoxicity within the panel of SiO2NP investigated. However, at these concentrations, we observed the onset of stress-related cellular response induced by SiO2NP. Interestingly, cells exposed to alumina-coated SiO2NP showed low level, and in some cases complete absence, of stress response and this was consistent up to the highest dose of 0.5 mg/ml.
The present study demonstrates and highlights the importance of subtle biological changes downstream of primary membrane and endocytosis-associated phenomena resulting from high dose SiO2NP exposure. Increased activation of transcription factors, such as ATF-2, was quantitatively assessed as a function of i) human cell line specific stress-response, ii) SiO2NP size and iii) concentration. Despite the low level of cytotoxicity detected for the amorphous SiO2NP investigated, these findings prompt an in-depth focus for future SiO2NP-cell/tissue investigations based on the combined analysis of more subtle signalling pathways associated with accumulation mechanisms, which is essential for establishing the bio-safety of existing and new nanomaterials.
Nanoparticles have received increasing attention for their potential applications in biology and medicine in recent years [1–3]. Notably, atmospheric particulates, such as diesel exhaust derivatives, have been recognized to have harmful effects on human health, including systemic and cardiovascular effects . Lately, there has been a growing awareness of the need to elucidate the underlying interactions between cells and nanomaterials in parallel with the development of nanomaterials applications, in order to ensure the safe implementation of nanotechnologies. This has become increasingly emphasised by many research groups worldwide in a large number of publications, in recent years [2, 3, 5–18]. As silica nanoparticles (SiO2NP) are extensively used in the biomedical field, for instance as biosensors for simultaneous assay of glucose , biomarkers for leukaemia cell identification using optical microscopy imaging , drug delivery , DNA delivery [20, 21], cancer therapy , and enzyme immobilization , it is important to understand any potential and unintended toxic, functional or signalling effects they may induce as a consequence of their increased cellular access, compared to their macroscale silica variants.
It has been reported that in vivo, in a mouse model, ultrafine colloidal silica particles (diameter < 100 nm) induce lung injury  and lung inflammation, which manifest as neutrophil accumulation at early stage of exposure (24 h) and chronic granulomatous inflammation at later stages (14 weeks) . Furthermore, several studies have also provided evidence that SiO2NP cause abnormal clusters of topoisomerase I in the nucleoplasm of cells, and pro-inflammatory stimulation both in vivo and in vitro[26–29].
Lin et al.  demonstrated in an in vitro study that amorphous SiO2NP (15 and 46 nm) significantly reduced the viability of human alveolar epithelial cells A549 in a dose- and time- dependent manner. They also found that nanometre-sized SiO2NP inhibited DNA replication, transcription, and cell proliferation. Low toxicity induced by 200 nm-size (hereafter refer as nm only) SiO2NP was reported by Wottrich et al. . Conversely, a study by Brunner et al. found that SiO2NP agglomerates (diameter > 200 nm) did not induce a toxic effect either in vivo or in vitro. Yu et al. also reported that amorphous silica nanoparticles below 100 nm did not induce any cytotoxicity measured by the mitochondrial viability assay .
In nanomaterial toxicity the study of the interaction of the reporter assay dye compounds with nanoparticles may cause significant interference with the assay performance, for instance due to fluorescence shift . Recently, a cell-based high content screening (HCS) assay operating on the principle of fully automated fluorescence microscopy was introduced as a modern drug discovery tool . This technology is becoming an indispensable approach to research and industry, assisting in understanding complex cellular processes in disease pathogenesis , drug target validation and drug lead identification [37–39]. HCS assays are especially useful in studying cytotoxicity of nanomaterials, because they allow for multiplexing of key reporter parameters such as cell viability, permeability, membrane potential, and lysosomal mass/pH [17, 40, 41]. Therefore special considerations have been given for the experimental design of the cell-nanoparticles interaction assessment to standardise every operation and remove potential sources of inconsistency [5–7, 40, 42].
To elucidate whether the SiO2NP can induce stress-related damage in living cells, the activation of transcription factor-2 (ATF-2), following exposure to the SiO2NPs, was investigated. ATF-2 is a member of the basic region-leucine zipper transcription factor family that regulates the expression of genes in response to various stress signals, and it is known to acquire its transcriptional activity upon phosphorylation by MAP kinases, including JNK and p38 [43, 44]. Because ATF-2 must be localised in the nucleus to induce gene expression, its translocation is a definitive measure of its activation, and marks an earlier event than reporter gene expression [44, 45].
The present experimental study was designed to carry out a mechanistic and systematic multiparametric quantitative analysis of human cells responses to SiO2NP of various sizes and concentrations utilising automated HCS approach. Despite a low toxic response to SiO2NP by all cell types in this study, as assessed by cell growth, lysosomal mass/pH and cell membrane integrity, we registered activation of gene stress marker ATF-2 thereby indicating the triggering of stress-related signalling pathways prior to the onset of "classical" signs of cytotoxicity.
Reagents and Antibodies
Dulbecco's modified Eagle medium (DMEM), RPMI 1640 and foetal bovine serum were from Gibco (Invitrogen, BioSciences Ltd., Dublin, Ireland). HitKit™ for ATF-2 activation and multiparametric cytotoxicity assay 1 (MPCT1) were from Thermo Fisher Scientific (Thermo Fisher Scientific Inc., USA). Rabbit monoclonal anti-JNK, anti-phospho-JNK, anti-p38, anti-phospho- p38 and horseradish peroxidase conjugated anti-rabbit antibodies were from Cell Signaling Technology (Danvers, MA, USA). PVDF membrane was obtained from Pall Gelman Laboratories (Ann arbor, MI, USA). Acrylamide-bisacrylamide solution, Acrylogel (30%) was purchased from BDH (VWR International Ltd., UK). ECL plus reagent was purchased from Amersham (Arlington Heights, IL, USA). All other reagents were from Sigma (St Louis, MO, USA), unless indicated otherwise.
Two human cell lines, one phagocytic and one non-phagocytic origin were used: a monocytic leukaemia THP-1 and an alveolar epithelial A549 (ATCC, Manassas, VA, USA). A549 cells were cultured in DMEM and THP-1 cells in RPMI 1640 medium. Both the culture media were supplemented with 10% foetal bovine serum, 200 mM L-glutamine, 10000 U/ml penicillin and 10 mg/ml streptomycin. For experimentation, A549 and THP-1 cells were seeded in 96-well plates at 5000 and 15000 respectively (Nunc, Inc., USA) and were maintained at 37°C and 5% CO2. THP-1 cells were stimulated with 25 ng/ml of phorbol 12-myristate 13-acetate for 72 h before SiO2NP exposure.
Three amorphous SiO2NP of different sizes (30, 80, and 400 nm) (Glantreo Ltd., Cork, Ireland) were evaluated and compared to commercially available Sigma Ludox 40 nm, positively charged alumina coated chloride-ion stabilized SiO2NP and 20 nm, sodium counterion stabilised SiO2NP (Sigma-Aldrich, LUDOX CL 420883 and LUDOX CL 420891 respectively). The physico-chemical properties of all chosen nanoparticles such as size, surface charge and pH have been fully characterised and previously reported by Barnes et al. , (for reference see Table 1, Barnes et al.) as part of a multisite evaluation of nanoparticle complete characterization (Nanointeract project under the European Union Framework Programme 6). These SiO2NP were used to study the cellular toxic and stress responses in 6 and 96 well plates of adherent cells exposed the above listed SiO2NP at various concentrations (0.01, 0.1, and 0.5 mg/ml) for 1, 3, 6, and 24 h incubation. All assays were performed in triplicate. After exposure, the cells were washed three times with culture medium to remove any unbound and non-internalised nanoparticles. Qualitative imaging of the SiO2NP cell uptake was enabled by the use of fluorescently labelled SiO2NP (produced also by Glantreo Ltd.). These were synthesised via a co-condensation reaction where Rhodamine 6G soluble dye was incorporated into the silica framework during the synthesis of the nanoparticles. It is known that by the incorporation of the dye within the silica framework, the dye release is prevented by the lack of charge transfer which is usually associated with a surface functionalisation of the fluorescent dye . Therefore, in our study when dispersed in biological, or water based solutions no obvious difference between the unlabelled and Rhodamine 6G labelled amorphous SiO2NP was found due to the complete amorphous nature of the mesoporous silica.
High content screening and confocal microscopy
As mentioned, for the imaging of NP intracellular localisation two custom modified fluorescently labelled SiO2NP (30 nm and 400 nm) were used. To determine if SiO2NP are endocytosed by active or passive transport routes, cells were incubated at 37°C and 4°C, to monitor active and passive diffusion, respectively. THP-1 and A549 cells were incubated with 0.01, 0.1 and 0.5 mg/ml of these labelled SiO2NP for intervals ranging from 15 minutes to 24 h in a 37°C incubator with 5% CO2. Then, cells were washed in phosphate-buffered saline solution (PBS) at pH 7.4 and fixed in 3% paraformaldehyde (PFA). For the 4°C assay, cells were exposed to the 0.1 mg/ml of labelled SiO2NP (30 nm) for 24 h, and then cells were fixed with 3% PFA. In order to observe the impact of passive transport on SiO2NP uptake, cells were pre-treated with sodium azide for 3 h (0.1%, 0.015 M).
High resolution intracellular accumulation of fluorescently labelled nanoparticles was visualized by confocal laser scanning microscopy (Carl Zeiss, Axiovert, Germany). Two channel qualitative imaging was carried out by acquiring a series of Z-stack images to verify the accumulation of the particles within the cells as a function of particle concentration and exposure time. Cellular uptake of labelled SiO2NP (time-course and dose-range) was further imaged and quantified using an automated IN Cell Analyzer 1000 HCA platform; (GE Healthcare, UK) and IN Cell Investigator software (GE Healthcare, UK), respectively.
Multiparameter cytotoxicity assay using HCS
A multiparametric cytotoxicity assay was performed using Cellomics® HCS reagent HitKit™ as per manufacturer's instructions (Thermo Fisher Scientific Inc., USA). This kit measures cell viability, cell membrane permeability and lysosomal pH which are toxicity-attributed phenomena. Variations in cell membrane permeability, measured as changes in luminescence intensity, indicated an enhancement of cell membrane damage and decreased cell viability. It is known some toxins can interfere with the cell's functionality by affecting the pH of organelles such as lysosomes and endosomes, or by causing an increase in the number of lysosomes. The dye used in the chosen cytotoxicity assay is a weak base that accumulates in acidic organelles, such as lysosomes and endosomes, which allows changes in lysosomal physiology to be determined. For instance, an increase or decrease in ph of acidic organelles and the changes in lysosome numbers by compound toxicity results in a decrease or an increased of fluorescence intensity, respectively.
In agreement with a previous study, we took a toxicity reference set by treating the cells with cisplatin (10 nM, Sigma-Aldrich), which is a platinum-based chemotherapy drug used to treat various types of cancers, including sarcomas, some carcinomas (e.g. small cell lung cancer, and ovarian cancer), lymphomas, and germ cell tumours . The experimental layout for the automated microscopic analysis, based on the In Cell analyzer 1000, was composed of untreated, cisplatin treated, and SiO2NP treated plates. All these were scanned and acquired in a stereology configuration of 6 randomly selected fields. Images were acquired at 10 X magnification using three detection channels with different excitation filters. These included a DAPI filter (channel 1), which detected blue fluorescence indicating nuclear intensity at a wavelength of 461 nm; FITC filter (channel 2), which detected green fluorescence indicating cell permeability at a wavelength of 509 nm and a TRITC filter (channel 3), which detected lysosomal mass and pH changes with red fluorescence at a wavelength of 599 nm.
The rate of cell viability and proliferation were assessed by the automated analysis of the nuclear count and morphology (DAPI filter); in parallel to the fluorescent staining intensities reflecting cell permeability (FITC filter) and lysosomal mass/pH changes (TRITC filter) were also quantified for each individual cell present in the examined microscopic fields by IN Cell Investigator (GE Healthcare, UK).
ATF-2 Activation Assay using HCS
ATF-2 activation was measured using Cellomics HitKit® as per manufacturer's instructions (Thermo Fisher Scientific Inc., USA). Briefly, cells seeded in 96-wells plates as described above were incubated with the above mentioned SiO2NP, for different intervals as previously indicated in the text, and in addition anisomycin was used as positive control (as supplied within the HitKit). For MAPK inhibition assay cells were pre-treated for 30 min with specific inhibitors for p38 (pyridinyl imidazole SB202190) or JNK (anthrapyraxolone SP600125) (Calbiochem, La Jolla, CA, USA). Exposed cells were then, washed in PBS, fixed with 3% PFA and stained for ATF-2 and nuclei (Hoechst). Plates were scanned, as previously described by using the principle of stereology in a randomly selected number of fields, using automated microscope (IN Cell Analyzer 1000 HCS platform, GE Healthcare, Buckinghamshire, UK) and images were acquired at 10 X magnification. Nuclear translocation of ATF-2 was quantified by IN Cell Investigator software using ad hoc nuclear trafficking analysis module (GE Healthcare, UK).
Cell Lysis and Immunoblotting
Exposed cells were washed with ice-cold PBS and lysed at 4°C for 30 min in 50 mM HEPES buffer (pH 7.4) containing NaCl 150 mM, MgCl2 1.5 mM, EGTA 1 mM, sodium pyrophosphate 10 mM, sodium fluoride 50 mM, β-glycerophosphate 50 mM, Na3VO4 1 mM, 1% Triton X-100, phenylmethylsulphonyl fluoride 2 mM, leupeptin 10 μg/ml and aprotinin 10 μg/ml. The resulting lysates were centrifuged at 16,000 × g for 15 min at 4°C and the protein content of the supernatants was determined by the Bradford assay. Cell lysates were boiled in Laemmli buffer (final concentration: Tris-HCl 62.5 mM, pH 6.7, Glycerol 10% v/v, sodium dodecyl sulphate 2% w/v, bromophenol blue 0.002% w/v and 143 mM β-mercaptoethanol) for 5 min. Equal amounts of lysates were resolved by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). The separated proteins were electrophoretically transferred to polyvinylidene fluoride (PVDF) membrane by semi-dry blotting for 1 h. The PVDF membranes were blocked in 5% non-fat dry milk in PBS Tween20 (PBST) [0.1% (v/v) Tween20 in phosphate buffered saline (PBS)] for 1 h at room temperature. After washing, the blots were incubated with the indicated primary antibodies (diluted according to manufacturer's instructions) overnight at 4°C with gentle rocking. After three washes in PBST, the membranes were incubated with the horseradish peroxidase conjugated secondary antibodies for 1 h at room temperature. The immunoreactive bands were visualized using an enhanced chemiluminescence detection system (Amersham, Arlington Heights, IL, US) and subsequent exposure to Kodak light sensitive film (Cedex, France).
The response of the two cell lines to the chosen SiO2NP sizes and concentrations was analyzed by 2-way ANOVA with Bonferroni post-test analysis with GraphPad Prism v4 (GraphPad Software, USA). A p-value of <0.05 was considered to be statistically significant. For the multiparametric analysis, due to the large amount of information acquired a data mining and exploration platform was used (KNIME (http://KNIME.org, 2.0.3) in combination with a screening module HiTS (http://code.google.com/p/hits, 0.3.0) in order to screen and normalised all parameters under investigation, as previously reported [49, 50]. All measured parameters were normalised using their respective percent of the positive controls. Z score was used for scoring the normalised values. These scores were summarised using the mean function as follows Z score = (x-mean)/StDev, as from previous work . Heatmaps graphical illustration in a colorimetric gradient table format was adopted as most suitable schematic representation to report on any statistical significance and variation from normalised controls based on their Z score value. Heatmaps tables illustrate the range of variation of each quantified parameter from the minimum (green) through the mean (yellow) to the maximum (red) accordingly to the parameter under analysis.
Densitometric analyses of the western blots were performed as described previously  using GeneTools software (Syngene, Cambridge, UK). The relative values of the samples were determined by normalising all data to the respective untreated control samples of each experiment.
Cellular uptake of SiO2NP
Two cell lines, a human monocytic leukemia cell line THP-1 and a human alveolar epithelial cell line A549 were chosen to represent a physiologically relevant model of the in vivo first line of interaction between nanoparticles and human tissues, as it would be expected following exposure of the lungs (inhalation) and uptake of foreign material by phagocytic system utilizing innate immunity mechanisms. Confirmation of fluorescently labelled SiO2NP (30 nm and 400 nm) uptake by both THP-1 and A549 cell lines was observed by confocal microscopy after 24 h (Figure 1A, 1B). Transmission electron microscopy (TEM) imaging clearly show the absence of significant aggregated clusters of 40 nm size alumina coated particles (Figure 1C) where particle size measurements have been also included for clarity. Further to this, Light Scattering measurement was also carried out on retrieved 40 nm particles, and this did not show any significant aggregation as shown in (Additional file 1, Figure S1).
The evaluation of the rate of the cellular uptake of the labelled SiO2NP, versus untreated controls, relative fluorescent intensity was quantified after 24 h exposure (Figure 2, 3). As expected for all SiO2NP, THP-1 cells rapidly engulfed these nanoparticles, with a maximum uptake for 30 nm labelled SiO2NP at 0.1 mg/ml and higher concentrations (0.5 mg/ml). When comparing the accumulation rate, THP-1 cells engulfed the SiO2NP at a faster rate than the A549 cells which is totally acceptable due to the specialist phagocytic nature of the THP-1 cells. In addition for both cell lines, the intracellular accumulation of the 400 nm-size SiO2NP was slower when compared to the 30 nm particles. Next, we investigated whether the cellular uptake of the SiO2NP was mediated by an energy-dependent mechanism; thus the cells were incubated at both 37°C and 4°C up to 24 h with fluorescently labelled 30 nm SiO2NPs (0.1 mg/ml). THP-1 and A549 cells incubated at 4°C exhibited a significant reduction in the SiO2NP uptake compared to the equivalent incubation at 37°C (Figure 3A, 3B). Moreover, by blocking the active transport mechanism of the A549 cells by sodium azide treatment this significantly impeded SiO2NP uptake, as shown in Figure 3B; this was not the case for the THP-1 cell line where the sodium azide was not sufficiently adequate to block the SiO2NP uptake (Figure 3A). However, increased concentrations of sodium azide significantly blocked the uptake of SiO2NP (data not shown).
Cell viability and proliferation assessment in response to SiO2NP
The assessment of cell-SiO2NP interaction by means of viability and proliferation of THP-1 and A549 cells respectively was performed by HCS on the all the chosen SiO2NP (20, 30, 40, 80, 400 nm) as fully described in the material section. In addition, for each particle size the results are presented in colorimetric gradients (heatmap format table), as shown in Figure 4 and 5 for THP-1 and A549 respectively and also by statistical analysis (Additional file 1, Table S1a-c). THP-1 did not show any obvious viability reduction up to 6 h when compared to the untreated cellular control (Figure 4, "cell viability" column for each particle size analysed (A, B, C, D, E, incubation time increasing from top to bottom). There, a significant decrease in the cell viability was seen for the sodium counterion stabilised (20 nm) SiO2NP at 0.1, or 0.5 mg/ml (Figure 4A), for the 30 nm SiO2NP at 0.5 mg/ml (Figure 4B), and for the 80 nm or 400 nm SiO2NP at 0.01, 0.1, or 0.5 mg/ml (Figure 4D, 4E). Interestingly, no significant effect in the THP-1 cell viability was recorded for any of the tested doses of the alumina coated positively charged SiO2NP (40 nm) (Figure 4C) up to 24 h, also confirmed by their statistical analysis tables (Additional file 1, Table S1a-c). Conversely to the THP-1 cell line, no detectable effect on A549 cell viability was observed by any of the SiO2NP type or doses investigated in this study (Figure 5A-E).
Changes in cell membrane permeability in response to SiO2NP
Further assessment of cell-SiO2NP interaction by means of cellular membrane permeability tests on THP-1 and A549 cells was performed by HCS on the all investigated SiO2NP (20, 30, 40, 80, 400 nm). In fact, it is known that the alterations of the cellular membrane permeability indicate the alterations of the physical condition of the cells . For THP-1 cells the cellular membrane permeability was significantly increased over 24 h exposures to 20, 30 or 80 nm-size SiO2NP at 0.5 mg/ml concentration (Figure 4A, 4B, 4D). On the other hand, no significant changes were seen for the 40 nm and 400 nm SiO2NP at any concentrations (Figure 4C, 4E).
For the A549 cells at concentration of 0.5 mg/ml, no significant changes in the cell membrane permeability was seen upon exposure to 20, 30, 40 and 80 nm SiO2NP at all tested doses and incubation times when compared to the untreated control cells (Figure 5A-D) and confirmed by ANOVA statistical test (Additional file 1, Table S2a-c). In contrast, the 400 nm-size SiO2NP caused cell membrane alteration at different incubation times, as shown in Figure 5E
Changes in lysosomal mass/pH in response to SiO2NP
The assessment of cell lysosomal mass/pH in response to a range of SiO2NP with different sizes (20, 30, 40, 80, 400 nm) was performed by HCS tool. A decrease or an increase of lysosomal mass/pH can designate an increased rate of the cytotoxicity. In this study, no significant changes were detected in lysosomal mass/pH staining intensity up to 6 h exposure to 20, 30, 80 nm SiO2NP at any of the concentrations tested in THP-1 cells. Conversely, the lysosomal mass/pH was markedly diminished in the THP-1 cells at the highest concentration (0.5 mg/ml) of the (20, 30 or 80 nm nanoparticles over 24 h exposure time (Figure 4A, 4B, 4D). However, 40 nm alumina coated SiO2NP and 400 nm-size uncoated SiO2NP did not induce any lysosomal mass/pH staining intensity changes for all tested doses in the THP-1 cell line, (Figure 4C, 4E). The lysosomal mass/pH staining intensity was increased in A549 cells following 24 h exposure to 20 and 80 nm SiO2NP at 0.5 mg/ml (Figure 5A, and 5D) and to 400 nm-size SiO2NP at 0.1 and 0.5 mg/ml concentrations (Figure 5E). Conversely, 40 nm alumina-coated SiO2NP did not induce any changes in the lysosomal mass/ph at any investigated concentrations in the A549 cells (Additional file 1, Table S3a-c).
SiO2NP induces ATF-2 nuclear translocation in cultured cells
To assess whether cells exposed to any of the SiO2NP under investigation showed gene stress response, we measured ATF-2 activation by nuclear translocation. A549 and THP-1 cells were exposed to SiO2NP for various time points (1, 3, 6, or 24 h) and ATF-2 nuclear translocation was measured by HCS system. ATF-2 was absent in the nuclei of untreated A549 cell (Figure 6) and THP-1 cells (data not shown). Quantitative analysis by HCS demonstrated that in both cell types ATF-2 underwent nuclear translocation upon nanoparticles exposure. The nuclear translocation of ATF-2 was size-dependent across the SiO2NP tested. For A549 cells, it resulted in a clear incremental dose-translocation proportion, starting from 3 h exposure; whereas for THP-1 cells this phenomenon was obvious after 6 h. In both cases it reached a plateau at 24 h exposure (Figure 7). Despite the similar dynamics of ATF-2 activation registered for both the cell lines, the overall activation level was lower in A549 cells than that observed in THP-1 cells (Figure 7B vs 7A). In addition, labelled SiO2NP also induced ATF-2 activation in both THP-1 and A549 cells (Figure 8A, 8B). This was not observed following the blocking of active transport mechanisms in THP-1 and A549 cell lines either by sodium azide treatment or by low temperature conditions (4°C)
SiO2NP induced activation of ATF-2 is dependent on JNK and p38
In addition to qualitative and quantitative assessment of the ATF-2 activation in both cell lines, we also investigated whether ATF-2 nuclear translocation in response to SiO2NP was dependent on earlier upstream changes in relevant intracellular signalling mechanisms. In the model of A549 cells we investigated if SiO2NP exposure involved intracellular signalling cascade pathways such as JNK and/or p38. It is known that the activation of ATF-2 results from phosphorylation at Ser 69/71 by either JNK or p38 kinase [44, 45]. Thus, A459 cells that had been exposed to SiO2NP (i.e., 80 nm) for varying time points ranging from 15 min to 24 h were analyzed for JNK or p38 activation by Western immunoblotting. We found that SiO2NP (80 nm) significantly increased the level of phosphorylated JNK1/2 as well as p38 in all cases when compared to untreated control cells (Figure 9A, 9B).
We next studied whether ATF-2 nuclear translocation in response to SiO2NP was dependent on p38 and/or JNK activation. For this purpose, specific inhibitors of these MAPK were utilised. A pyridinyl imidazole SB202190 and an anthrapyraxolone SP600125 are well-characterised and specific inhibitors of p38 and JNK respectively [54–56]. Pre-treatment of the cells with SB202190 (10 μM) blocked SiO2NP-induced ATF-2 nuclear translocation (Figure 10). Similarly, pre-treatment of the cells with anthrapyraxolone SP600125 (10 μM) significantly reduced SiO2NP-induced ATF-2 nuclear translocation (Figure 10). Together, these results confirmed that SiO2NP induced ATF-2 activation was dependent on p38 and JNK, further supporting their roles in the activation of ATF-2.
In this study, we explored the potential cytotoxic effect of SiO2NP of five sizes (20, 30, 40, 80 and 400 nm), and dose-ranges from 0.01 to 0.5 mg/ml, in two cultured human cells of diverse origin: (i) a phagocytic cell line THP-1, and (ii) a lung epithelial cell line A549. We have demonstrated the cellular uptake of SiO2NP by confocal microscopy and HCS in both the cell lines. Active or passive transport routes of SiO2NP endocytosis were examined by temperature controlled assays at 37°C or 4°C, respectively. To further expand this work and gain a deeper understanding on the subtle cell stress variation at molecular level we investigated the activation of transcription factor-2 (ATF-2). To date, this is the first quantitative study showing treatment of human cell lines with SiO2NP (unstabilised or sodium stabilized) induces activation of ATF-2 in a dose- and time-dependent manner. This activation was found to be dependent on JNK and p38 kinase-mediated signalling pathways and we have shown that JNK and p38 are phosphorylated by SiO2NP treatment of cells. The involvement of p38 cell stress activated pathway is also supported by the evidence that cigarette smoke particles induced activation of the p38 MAPK inflammatory signalling and phosphorylation of its downstream ATF-2 .
In this work, we observed that 30 nm SiO2NP were more rapidly taken up by both THP-1 and A549 cells than the nominally 400 nm SiO2NP (made by the same synthesis route and with similar surface characteristics). Rapid internalisation was seen after 1 hr incubation at both SiO2NP which then turned out to be a size-dependent endocytotic process possibly associated with two competing mechanisms such as diffusion (after 1 h) and sedimentation (after 3 h). This has been previously reported by Limbach and co-workers  as a particle transport mechanism issue which has been associated with the nature of the cell under investigation and the quantitative treatment of the nanomaterial under investigation. A recent work from Shapero and co-workers , described and explained the detailed uptake and localization time course of SiO2NP of different sizes (50, 100 and 300 nm) by one of the cell line used, in this work A549 cells.
In agreement with previous studies , we have also demonstrated that the SiO2NP uptake was eliminated at lower temperature (4°C) in THP-1 and A549 cells . Sodium azide is widely used both in vivo and in vitro as an inhibitor of cellular respiration. It acts by inhibiting cytochrome C oxidase, the last enzyme in the mitochondrial electron transport chain, and thereby produces a drop in intracellular ATP concentration . The uptake of SiO2NP into A549 pre-treated with commonly used concentration of sodium azide (0.1%) was completely blocked thus suggesting that the uptake mechanism occurs through an energy dependent process. In contrast, this concentration of sodium azide could not efficiently inhibit SiO2NP uptake in THP-1 cells. Other studies have also reported on alternative uptake mechanisms such as clathrin-mediated endocytosis, caveolae/lipid raft-mediated endocytosis, macropinocytosis, or phagocytosis [62, 63].
In light of this evidence, a broader understanding on the mechanism of interaction between the nanoparticles and cell lines used was also explored since each of the cell lines exhibited different responses to the various SiO2NP. Overall the HCS measured cytotoxicity was higher in THP-1 compared to A549 cells. In addition, THP-1 cells showed reduction in the cell viability, as shown in Figure 4. This reduction is dependent on the particle concentration, particle size, and exposure time. It has been previously reported by other researchers that the reduction of cell viability is concentration-dependent [30, 64–66]. The issue of size-dependent cytotoxicity of SiO2NP has previously been addressed in different cell systems such as A549, Mono Mac 6 and THP-1 and EAHY926 cell lines [66, 67]. It has been shown in vivo that amorphous SiO2NP are less toxic than their crystalline form [68, 69].
We have also demonstrated a particle size-dependence of the cytotoxic response in THP-1 cells. As seen in Figures 4, the smaller sizes (20, and 30 nm) of the tested sodium ion stabilized, and non- stabilized SiO2NP at 0.5 mg/ml caused an inhibition in cell viability after 24 h incubation period. Whereas, all tested doses of the 80 and 400 nm-size SiO2NP caused a significant decrease in the viability of THP-1 cells. We observed that the peak of internalised 400 nm SiO2NP remained constant in the cytosol of THP-1 cells after 24 h exposure, while the cellular uptake level of 30 nm SiO2NP decreased after 24 h exposure. From this, we hypothesise that the large sized particles (400 nm SiO2NP) either remained within the cells or a delay in the exocytosis process induced significant decrease of the cell viability. This emphasises the need to further address the bi-directional issues (endo- and exo- cytotic process) involving the nanoparticle transport routes and mechanisms in human cells.
A549 cells are a well characterised in vitro model and have been extensively used for assessing cytotoxicity, including nanomaterials-induced cytotoxicity [70, 71]. The findings of these works show that there was no significant reduction in cell viability caused by any of the tested SiO2NP at any of the doses applied (0.01, 0.1, and 0.5 mg/ml). Conversely to previous work by Lin et al.  which showed a significant reduction in the viability of A549 cells caused by 15 nm and 46 nm amorphous SiO2NP that exhibited similar cytotoxicity. Their conclusion was that the 15 nm and 46 nm SiO2NP aggregated to form hydrodynamic clusters of ranging sizes between 590 nm to 617 nm, respectively with subsequent toxicity due to their aggregation . Conversely, we did not find a significant reduction in cell number even at the highest concentration tested (0.5 mg/ml) either by 20 nm nor 400 nm SiO2NP. In our study, the size and size-distribution of the SiO2NP used here were extensively examined and characterised across the Nanointeract consortium (Framework Programme 6 funded project), as reported by Barnes et al. ; this is an important consideration when using the nanoparticles for biomedical applications. In addition, our TEM and Light Scattering measurement was also carried out on retrieved 40 nm particles, and this did not show any significant aggregation.
To determine if surface coating of the SiO2NP affects the cellular interaction, we also evaluated the effect of alumina coating on SiO2NP cytotoxicity. We found that the alumina coating of positively charged SiO2NP did not significantly inhibit cell growth, at any dose, in any of the two cell types studied. In vitro studies also suggested that alumina coating pre-treatment reduced the cytotoxicity of silica  and mitochondrial depolarisation . The mechanism by which alumina coating reduces silica toxicity is still unclear, nonetheless our latest findings are in opposition with the general perception that cationic species are more toxic to cells than anionic ones , and this was consistent for both the cytotoxicity and activation of ATF-2 translocation. Furthermore, it has been suggested that alumina reduces the ability of silica to generate hydroxyl radicals in the presence of hydrogen peroxide  and their effects are believed to alter the interaction of SiO2NP with cell membranes . This was demonstrated in our study by the investigation of the 40 nm alumina coated SiO2NP which suppressed the lysosomal alterations in both THP-1 and A549 cells.
Following the uptake of SiO2NP, these may interact with phagolysosomal membranes leading to the release of lysosomal enzymes into the cytosol and subsequently causing cell death in phagocytic cells , or epithelial cells . This was qualitatively and quantitatively assessed in this work. For instance, despite the reduction of cell viability of THP-1 cells at concentrations below 0.5 mg/ml, the lysosomal mass/pH changes were only noted at the highest 0.5 mg/ml of 20, 30 and 80 nm SiO2NP. This is in agreement with previous work by some of the authors where they demonstrated such alteration of lysosomal mass/pH in THP-1 to be linked to nanoparticles and also the cell line used .
For the human lung epithelial cell line A549, the lysosomal mass/pH was increased following treatment with nominally 20, 80 or 400 nm particles and the latter SiO2NP used caused some cell biological changes (e.g. cell stress, membrane permeability, and lysosomal mass/pH), despite cell proliferation was not inhibited as shown by the cell viability measurements. In fact, it has been suggested that loss in lysosomal integrity can be attributed to apoptotic responses , sphingosine , TNF-α , Fas , lysosomal photodamage  or lysosomal permeability . Importantly, in this study we found that alumina coated 40 nm SiO2NP showed lower cytotoxicity in all measured parameters and lower ATF-2 activation stress response. This might be linked to a possible reduction by the SiO2NP to produce hydroxyl radicals in situ in cells. From the results presented in this study, we propose that SiO2NP enter the cells by endocytosis and activate the SAPK pathway. Activated JNK and p38 further trigger the nuclear translocation of transcription factor ATF-2 with a consequent induction of stress response signalling pathways (Figure 11).
Finally, our results are in agreement with other cytotoxicity studies [31, 32, 83] demonstrating low cytotoxicity response induced by SiO2NP (below <500 nm). However, in this paper we present further evidence of gene stress response induced by these materials, which has not been previously measured by other techniques [46, 61]. This opens interesting exploratory pathway where there is a pressing need for further in-depth gene-associated studies towards the elucidation of the SiO2NP-cells interaction mechanisms aimed at establishing the safe application of this promising nanomaterials.
This study showed that at concentrations below 0.5 mg/ml of the amorphous SiO2NP tested (20, 30, 40, 80 and 400 nm), a low degree of cytotoxicity was observed across the two cell lines adopted (THP-1 and A549 cells). Interestingly, the cell lines did not show any significant toxic response to the alumina coated SiO2NP (e.g., 40 nm SiO2NP). In this paper, we demonstrated for the first time that SiO2NP are able to induce p38 and JNK MAPK activation and phosphorylation of their downstream ATF-2 target, which also clearly reflect the nature of particular cell type. In addition, we also registered a close relation between silica-induced cytotoxicity and changes to the structure or activity of detected cellular compartments (e.g., lysosomal and cell membrane) by the use of HCS which detected significant dose and particle size-dependent changes in parameters related to these compartments.
Based on our results, it may be speculated that continuous exposure to nanoparticles, even of relatively biologically "inert" nature, could impose a risk to human health. However, it may be possible to reduce such unwanted effects by surface modification of nanomaterials, for example via alumina coating of SiO2NP, thereby reducing the surface reactivity of the NPs. A much better mechanistic understanding of nanoparticles and their properties will support the development and evaluation of potentially reduced risk nano-products for biomedical applications, and HCS offers an ideal platform for the type of screening data needed for this purpose.
high content screening
activation transcription factor-2
phorbol 12-myristate 13-acetate
multiparameter cytotoxicity assay 1.
Zhang FF, Wan Q, Li CX, Wang XL, Zhu ZQ, Xian YZ: Simultaneous assay of glucose, lactate, L-glutamate and hypoxanthine levels in a rat striatum using enzyme electrodes based on neutral red-doped silica nanoparticles. Anal Bioanal Chem. 2004, 380: 637-642. 10.1007/s00216-004-2804-x.
Oberdorster G, Oberdorster E, Oberdorster J: Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect. 2005, 113: 823-839. 10.1289/ehp.7339.
Nel A, Xia T, Madler L, Li N: Toxic potential of materials at the nanolevel. Science. 2006, 311: 622-627. 10.1126/science.1114397.
Zhao J, Xie Y, Qian X, Jiang R, Song W: Acute effects of fine particles on cardiovascular system: differences between the spontaneously hypertensive rats and wistar kyoto rats. Toxicol. Lett. 2010, 193: 50-60. 10.1016/j.toxlet.2009.12.002.
Williams Y, Byrne S, Bashir M, Davies A, Whelan A, Gun'ko Y: Comparison of three cell fixation methods for high content analysis assays utilizing quantum dots. J Microsc. 2008, 232: 91-98. 10.1111/j.1365-2818.2008.02083.x.
Nabiev I, Mitchell S, Davies A, Williams Y, Kelleher D, Moore R: Nonfunctionalized nanocrystals can exploit a cell's active transport machinery delivering them to specific nuclear and cytoplasmic compartments. Nano Lett. 2007, 7: 3452-3461. 10.1021/nl0719832.
Byrne SJ, Williams Y, Davies A, Corr SA, Rakovich A, Gun'ko YK: "Jelly dots": synthesis and cytotoxicity studies of CdTe quantum dot-gelatin nanocomposites. Small. 2007, 3: 1152-1156. 10.1002/smll.200700090.
Balshaw DM, Philbert M, Suk WA: Research strategies for safety evaluation of nanomaterials, Part III: nanoscale technologies for assessing risk and improving public health. Toxicol. Sci. 2005, 88: 298-306. 10.1093/toxsci/kfi312.
Borm PJ, Muller-Schulte D: Nanoparticles in drug delivery and environmental exposure: same size, same risks?. Nanomedicine (Lond). 2006, 1: 235-249. 10.2217/174358126.96.36.199.
Donaldson K, Ston V, Tran CL, Kreyling W, Borm PJ: Nanotoxicology. Occup Environ Med. 2004, 61: 727-728. 10.1136/oem.2004.013243.
Holsapple MP, Farland WH, Landry TD, Monteiro-Riviere NA, Carter JM, Walker NJ: Research strategies for safety evaluation of nanomaterials, part II: toxicological and safety evaluation of nanomaterials, current challenges and data needs. Toxicol Sci. 2005, 88: 12-17. 10.1093/toxsci/kfi293.
Thomas T, Thomas K, Sadrieh N, Savage N, Adair P, Bronaugh R: Research strategies for safety evaluation of nanomaterials, part VII: evaluating consumer exposure to nanoscale materials. Toxicol Sci. 2006, 91: 14-19. 10.1093/toxsci/kfj129.
Powers KW, Brown SC, Krishna VB, Wasdo SC, Moudgil BM, Roberts SM: Research strategies for safety evaluation of nanomaterials. Part VI. Characterization of nanoscale particles for toxicological evaluation. Toxicol Sci. 2006, 90: 296-303.
Warheit DB, Borm PJ, Hennes C, Lademann J: Testing strategies to establish the safety of nanomaterials: conclusions of an ECETOC workshop. Inhal Toxicol. 2007, 19: 631-643. 10.1080/08958370701353080.
Thomas K, Sayre P: Research strategies for safety evaluation of nanomaterials, Part I: evaluating the human health implications of exposure to nanoscale materials. Toxicol Sci. 2005, 87: 316-321. 10.1093/toxsci/kfi270.
Jan E, Byrne SJ, Cuddihy M, Davies AM, Volkov Y, Gun'ko YK: High-content screening as a universal tool for fingerprinting of cytotoxicity of nanoparticles. ACS Nano. 2008, 2: 928-938. 10.1021/nn7004393.
Tsuji JS, Maynard AD, Howard PC, James JT, Lam CW, Warheit DB: Research strategies for safety evaluation of nanomaterials, part IV: risk assessment of nanoparticles. Toxicol Sci. 2006, 89: 42-50.
Stark WJ: Nanoparticles in biological systems. Angew Chem Int Ed Engl. 2011, 50: 1242-1258. 10.1002/anie.200906684.
Venkatesan N, Yoshimitsu J, Ito Y, Shibata N, Takada K: Liquid filled nanoparticles as a drug delivery tool for protein therapeutics. Biomaterials. 2005, 26: 7154-7163. 10.1016/j.biomaterials.2005.05.012.
Bharali DJ, Klejbor I, Stachowiak EK, Dutta P, Roy I, Kaur N: Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. Proc Natl Acad Sci USA. 2005, 102: 11539-11544. 10.1073/pnas.0504926102.
Gemeinhart RA, Luo D, Saltzman WM: Cellular fate of a modular DNA delivery system mediated by silica nanoparticles. Biotechnol Prog. 2005, 21: 532-537.
Hirsch LR, Stafford RJ, Bankson JA, Sershen SR, Rivera B, Price RE: Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc Natl Acad Sci USA. 2003, 100: 13549-13554. 10.1073/pnas.2232479100.
Qhobosheane M, Santra S, Zhang P, Tan W: Biochemically functionalized silica nanoparticles. Analyst. 2001, 126: 1274-1278. 10.1039/b101489g.
Kaewamatawong T, Kawamura N, Okajima M, Sawada M, Morita T, Shimada A: Acute pulmonary toxicity caused by exposure to colloidal silica: particle size dependent pathological changes in mice. Toxicol Pathol. 2005, 33: 743-749.
Cho WS, Choi M, Han BS, Cho M, Oh J, Park K: Inflammatory mediators induced by intratracheal instillation of ultrafine amorphous silica particles. Toxicol Lett. 2007, 175: 24-33. 10.1016/j.toxlet.2007.09.008.
Chen Y, Chen J, Dong J, Jin Y: Comparing study of the effect of nanosized silicon dioxide and microsized silicon dioxide on fibrogenesis in rats. Toxicol Ind Health. 2004, 20: 21-27. 10.1191/0748233704th190oa.
Peters K, Unger RE, Kirkpatrick CJ, Gatti AM, Monari E: Effects of nano-scaled particles on endothelial cell function in vitro: studies on viability, proliferation and inflammation. J Mater Sci Mater Med. 2004, 15: 321-325.
Chen M, von MA: Formation of nucleoplasmic protein aggregates impairs nuclear function in response to SiO2 nanoparticles. Exp Cell Res. 2005, 305: 51-62. 10.1016/j.yexcr.2004.12.021.
Park EJ, Yi J, Chung KH, Ryu DY, Choi J, Park K: Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol Lett. 2008, 180: 222-229. 10.1016/j.toxlet.2008.06.869.
Lin W, Huang YW, Zhou XD, Ma Y: In vitro toxicity of silica nanoparticles in human lung cancer cells. Toxicol Appl Pharmacol. 2006, 217: 252-259. 10.1016/j.taap.2006.10.004.
Wottrich R, Diabate S, Krug HF: Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co-culture. Int J Hyg Environ Health. 2004, 207: 353-361. 10.1078/1438-4639-00300.
Brunner TJ, Wick P, Manser P, Spohn P, Grass RN, Limbach LK: In vitro cytotoxicity of oxide nanoparticles: comparison to asbestos, silica, and the effect of particle solubility. Environ Sci Technol. 2006, 40: 4374-4381. 10.1021/es052069i.
Yu KO, Grabinski CM, Schrand AM, Murdock RC, Wang W, Gu B, Schlager JJ, Hussain SM: Toxicity of amorphous silica nanoparticles in mouse keratinocytes. J Nanopart Res. 2009, 11: 15-24. 10.1007/s11051-008-9417-9.
Worle-Knirsch JM, Pulskamp K, Krug HF: Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nano Lett. 2006, 6: 1261-1268. 10.1021/nl060177c.
Perlman ZE, Slack MD, Feng Y, Mitchison TJ, Wu LF, Altschuler SJ: Multidimensional drug profiling by automated microscopy. Science. 2004, 306: 1194-1198. 10.1126/science.1100709.
Mohamed BM, Feighery C, Williams Y, Davies A, Kelleher D, Volkov Y, Kelly J, Abuzakouk M: The use of Cellomics to study enterocyte cytoskeletal proteins in coeliac disease patients. Cent Eur J Biol. 2008, 3: 258-267. 10.2478/s11535-008-0029-2.
Zhou X, Wong S: High content cellular imaging for drug development. IEEE Signal Processing Magazine. 2006, 23: 170-174.
Zhou X, Wong S: Informatics challenges of high-throughputmicroscopy. IEEE Signal Processing Magazine. 2006, 23: 63-672.
Long A, Volkov Y: High Content Analysis approach for targeted gene silencing and probing nanoscale cell responses. European Pharmaceutical Reviews. 2009, 1: 22-30.
Byrne F, Prina-Mello A, Whelan A, Mohamed BM, Davies A, Gun ko Y, Coey JMD, Volkov Y: High content analysis of the biocompatibility of nickel nanowires. The Journal of Magnetism and Magnetic Materials. 2009, 321: 1341-1345. 10.1016/j.jmmm.2009.02.035.
Movia D, Prina-Mello A, Volkov Y, Giordani S: Determination of spiropyran cytotoxicity by high content screening and analysis for safe application in bionanosensing. Chem Res Toxicol. 2010, 23: 1459-1466. 10.1021/tx100123g.
George S, Pokhrel S, Xia T, Gilbert B, Ji Z, Schowalter M, Rosenauer A, Damoiseaux R, Bradley KA, Madler L, Nel AE: Use of a rapid cytotoxicity screening approach to engineer a safer zinc oxide nanoparticle through iron doping. ACS Nano. 2010, 4: 15-29. 10.1021/nn901503q.
Van Dam H, Wilhelm D, Herr I, Steffen A, Herrlich P, Angel P: ATF-2 is preferentially activated by stress-activated protein kinases to mediate c-jun induction in response to genotoxic agents. EMBO J. 1995, 14: 1798-1811.
Gupta S, Campbell D, Derijard B, Davis RJ: Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 1995, 267: 389-393. 10.1126/science.7824938.
Li XY, Green MR: Intramolecular inhibition of activating transcription factor-2 function by its DNA-binding domain. Genes Dev. 1996, 10: 517-527. 10.1101/gad.10.5.517.
Barnes CA, Elsaesser A, Arkusz J, Smok A, Palus J, Lesniak A: Reproducible comet assay of amorphous silica nanoparticles detects no genotoxicity. Nano Lett. 2008, 8: 3069-3074. 10.1021/nl801661w.
Gilliland JW, Yokoyama K, Yip WT: Comparative study of guest charge-charge interactions within silica sol-gel. J Phys Chem B. 2005, 109: 4816-4823. 10.1021/jp0458957.
Pruefer FG, Lizarraga F, Maldonado V, Melendez-Zajgla J: Participation of Omi Htra2 serine-protease activity in the apoptosis induced by cisplatin on SW480 colon cancer cells. J Chemother. 2008, 20: 348-354.
Kozak K, Bakos G, Hoff A, Bennett E, Dunican D, Davies A, Kelleher D, Long A, Csucs G: Workflow-based software environment for large-scale biological experiments. J Biomol Screen. 2010, 15: 892-899. 10.1177/1087057110377354.
Freeley M, Bakos G, Davies A, Kelleher D, Long A, Dunican D: A high-content analysis toolbox permits dissection of diverse signaling pathways for T lymphocyte polarization. J Biomol Screen. 2010, 15: 541-555. 10.1177/1087057110369703.
Birmingham A, Selfors LM, Forster T, Wrobel D, Kennedy CJ, Shanks E: Statistical methods for analysis of high-throughput RNA interference screens. Nat Methods. 2009, 6: 569-575. 10.1038/nmeth.1351.
Verma NK, Dempsey E, Conroy J, Olwell P, Mcelligott AM, Davies : A new microtubule-targeting compound PBOX-15 inhibits T-cell migration via post-translational modifications of tubulin. J Mol Med. 2008, 86: 457-469. 10.1007/s00109-008-0312-8.
Mingeot-Leclercq MP, Brasseur R, Schanck A: Molecular-parameters involved in aminoglycoside nephrotoxicity. J Toxicol EnViron Health. 1995, 44: 263-300. 10.1080/15287399509531960.
Wang W, Shi L, Xie Y, Ma C, Li W, Su X: SP600125, a new JNK inhibitor, protects dopaminergic neurons in the MPTP model of Parkinson's disease. Neurosci Res. 2004, 48: 195-202. 10.1016/j.neures.2003.10.012.
Muniyappa H, Das KC: Activation of c-Jun N-terminal kinase (JNK) by widely used specific p38 MAPK inhibitors SB202190 and SB203580: a MLK-3-MKK7-dependent mechanism. Cell Signal. 2008, 20: 675-683. 10.1016/j.cellsig.2007.12.003.
Zhang YL, Dong C: MAP kinases in immune responses. Cell Mol Immunol. 2005, 2: 20-27.
Vikman PB, Xu C, Edvinsson L: Lipid-soluble cigarette smoking particles induce expression of inflammatory and extracellular-matrix-related genes in rat cerebral arteries. Vasc Health Risk Manag. 2009, 5: 333-341.
Limbach LK, Li Y, Grass RN, Brunner TJ, Hintermann MA, Muller M, Gunther D, Stark WJ: Oxide nanoparticle uptake in human lung fibroblasts: effects of particle size, agglomeration, and diffusion at low concentrations. Environ Sci Technol. 2005, 39: 9370-9376. 10.1021/es051043o.
Shapero K, Fenaroli F, Lynch I, Cottell DC, Salvati A, Dawson KA: Time and space resolved uptake study of silica nanoparticles by human cells. Mol Biosyst. 2011, 7: 371-378. 10.1039/c0mb00109k.
Kim JS, Yoon TJ, Yu KN, Noh MS, Woo M, Kim BG, Lee KH, Sohn BH, Park SB, Lee JK, Cho MH: Cellular Uptake of Magnetic Nanoparticle Is Mediated Through Energy-Dependent Endocytosis in A549 Cells. J Vet Sci. 2006, 7: 321-326.
Torchilin VP, Rammohan R, Weissig V, Levchenko TS: TAT Peptide on the Surface of Liposomes Affords Their Efficient Intracellular Delivery Even at Low Temperature and in the Presence of Metabolic Inhibitors. Proc Natl Acad Sci USA. 2001, 98: 8786-8791. 10.1073/pnas.151247498.
Wang ZY, Zhao Y, Ren L, Jin LH, Sun LP, Yin P, zhang YF, Zhang QQ: Novel gelatin-siloxane nanoparticles decorated by Tat peptide as vectors for gene therapy. Nanotechnology. 2008, 19: 445103-10.1088/0957-4484/19/44/445103.
Ge D, Wu D, Wang Z, Shi W, Wu T, Zhang A, Hong S, Wang J, Zhang Y, Ren L: Cellular uptake mechanism of molecular umbrella. Bioconjug Chem. 2009, 12: 2311-2316.
Wang JJ, Sanderso BJ, Wang H: Cytotoxicity and genotoxicity of ultrafine crystalline SiO2 particulate in cultured human lymphoblastoid cells. Environ Mol Mutagen. 2007, 48: 151-157. 10.1002/em.20287.
Wottrich R, Diabate S, Krug HF: Biological effects of ultrafine model particles in human macrophages and epithelial cells in mono- and co-culture. Int J Hyg Environ Health. 2004, 207: 353-361. 10.1078/1438-4639-00300.
Napierska D, Thomassen LC, Rabolli V, Lison D, Gonzalez L, Kirsch-Volders M, Martens JA, Hoet PH: Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small. 2009, 5: 846-853. 10.1002/smll.200800461.
Yamamoto A, Honma R, Sumita M, Hanawa T: Cytotoxicity evaluation of ceramic particles of different sizes and shapes. J Biomed Mater Res A. 2004, 68: 244-256.
Kelley DP, Lee KP: "Pulmonary response to Ludox colloidal silica inhalation exposure in rats". Toxicologist. 1990, 10: 202A-
Warheit DB, McHugh TA, Hartsky MA: "Differential pulmonary responses in rats inhaling crystalline, colloidal or amorphous silica dusts". Scand J Work Environ Health. 1995, 2: 19-21.
Huang M, Khor E, Lim LY: Uptake and cytotoxicity of chitosan molecules and nanoparticles: effects of molecular weight and degree of deacetylation. Pharm Res. 2004, 21: 344-353.
Bakand S, Winder C, Khalil C, Hayes A: A novel in vitro exposure technique for toxicity testing of selected volatile organic compounds. J Environ Monit. 2006, 8: 100-105. 10.1039/b509812b.
Knaapen AM, Shi T, Borm PJ, Schins RP: Soluble metals as well as the insoluble particle fraction are involved in cellular DNA damage induced by particulate matter. Mol Cell Biochem. 2002, 234-235: 317-326. 10.1023/A:1015970023889.
Thibodeau M, Giardina C, David A, Joseph Helble, Hubbard AK: Silica-Induced Apoptosis in Mouse Alveolar Macrophage is Initiated by Lysosomal Enzyme Activity. Toxicol Sci. 2004, 76: 91-101.
Dawson KA, Salvati A, Lynch I: "Nanotoxicology: nanoparticles reconstruct lipids". Nat Nanotechnol. 2009, 4.2: 84-85.
Fubini B: Surface chemistry and quartz hazard. Ann Occup Hyg. 1998, 42: 521-530.
Erdogdu G, Hasirci V: An overview of the role of mineral solubility in silicosis and asbestosis. Environ Res. 1998, 78: 38-42. 10.1006/enrs.1998.3842.
Nadler S, Goldfischer S: The intracellular release of lysosomal contents in macrophagesthat have ingested silica. J Histochem Cytochem. 1970, 18: 368-371. 10.1177/18.5.368.
Brunk UT, Svensson I: Oxidative stress, growth factor starvation and Fas activationmayall cause apoptosis through lysosomal leak. Redox Rep. 1999, 4: 3-11. 10.1179/135100099101534675.
Kagedal K, Zhao M, Svensson I, Brunk UT: Sphingosine induced apoptosis is dependent on lysosomal proteases. Biochem J. 2001, 359: 335-343. 10.1042/0264-6021:3590335.
Werneburg NW, Guicciardi ME, Bronk SF, Gores GJ: Tumor necrosis factor-a-associated lysosomal permeabilization is cathepsin B dependent. Am J Physiol Gastrointest Liver Physiol. 2002, 283: G947-G956.
Reiners JJ, Caruso JA, Mathieu P, Chelladurai B, Yin XM, Kessel D: Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ. 2002, 9: 934-944.
Chang JS, Chang KL, Hwang DF, Kong ZL: In vitro cytotoxicitiy of silica nanoparticles at high concentrations strongly depends on the metabolic activity type of the cell line. EnViron Sci Technol. 2007, 41: 2064-2068. 10.1021/es062347t.
Jin Y, Kannan S, Wu M, Zhao JX: Toxicity of luminescent silica nanoparticles to living cells. Chem Res Toxicol. 2007, 20: 1126-1133. 10.1021/tx7001959.
This work was partially funded by the EU FP6 project NanoInteract (NMP4-CT-2006-033231) and EU FP7 project NAMDIATREAM (NMP-2009-246479) Valuable frequent and critical discussions with the entire NanoInteract and NAMDIATREAM consortium are gratefully acknowledged. The authors would like to thank Ms Greta Kerins.
The authors declare that they have no competing interests.
BMM aided in the conception of the study, drafted the manuscript and performed all assays. NKV, YW, AD, APM contributed to the experimental design, and made scientific contributions to the study. CE participated in the assay development. GB, BMM, APM performed the statistical analysis, and heatmaps table illustrations generations. LT, APM, and DK participated in the critical assessment of the data, and drafting of the manuscript. JH synthesised and supplied the Glantreo SiO2NP, and the fluorescently-labelled SiO2NP. AS, IL, and KD provided the silica particle characterisation, and contributed to the critical assessment of the data and drafting of the manuscript. YV supervised the study and participated in the data analysis and drafting of the manuscript. All authors have read and approved the final manuscript.
Electronic supplementary material
Additional file 1:Supplemental information to manuscript. Light scattering measurements of alumina-coated particles (Ludox CL 420883), plot of two independent batches of Ludox particles suspended in DI water and statistical analysis tables for cell viability, membrane permeability and lysosomal mass/pH parameters. (DOCX 83 KB)
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Mohamed, B.M., Verma, N.K., Prina-Mello, A. et al. Activation of stress-related signalling pathway in human cells upon SiO2 nanoparticles exposure as an early indicator of cytotoxicity. J Nanobiotechnol 9, 29 (2011). https://doi.org/10.1186/1477-3155-9-29
- A549 Cell
- Alumina Coating
- High Content Screening
- Lung Epithelial Cell Line
- Light Scatter Measurement